MBD2 and acute myeloid leukemia: Compared with the WT conditions, the loss of MBD2 significantly decreased the number of white blood cells (WBCs) and leukemic cell infiltration in the peripheral blood, which was consistent with the reduced leukemia burden in Mbd2−/− AML mice (Supplementary Fig. S3C).